Legatum Lecture Series Presents: Alpheus Bingham of Innocentive, Inc.
The Long Tail of Expertise
Founder, Board Member, InnoCentive, Inc.
Dr. Alpheus Bingham is a pioneer in the field of open innovation and an advocate of collaborative approaches to research and development. He is co-founder and former president and chief executive officer of InnoCentive, Inc.
Alph spent more than 25 years with Eli Lilly and Company; he retired as vice president of e.Lilly and vice president of Research Strategy. During his career he was instrumental in creating and developing Lilly's portfolio management process and establishing the divisions of Research Acquisitions, the Office of Alliance Management, and e.Lilly, a business innovation unit, from which was launched various other ventures that create the advantages of open and networked organizational structures, including InnoCentive, YourEncore, Inc., Coalesix, Inc., Maaguzi, Inc., Indigo Biosystems, Seriosity, Chorus, and Collaborative Drug Discovery, Inc.
He currently serves on the Board of Directors of InnoCentive, Inc., and Collaborative Drug Discovery, Inc. and the advisory boards of the Center for Collective Intelligence at MIT and the Business Innovation Factory.
He has lectured extensively at both national and international events and serves as a Visiting Scholar at the National Center for Supercomputing Application at the University of Illinois at Champaign-Urbana. He is also the former chairman of the Board of Editors of the Research Technology Management Journal. Dr. Bingham was the recipient of The Economist's Fourth Annual Innovation Summit "Business Process Award" for InnoCentive.